無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

生物製剤・バイオシミラーの世界市場の予測

Global Biologics and Biosimilars Market Size study, by Type(Antibody, Hormone, Growth Factors), by Applications (Tumor, Diabetes, Cardiovascular, Hemophilia, Other), by and Regional Forecasts 2018-2025

発行 Bizwit Research & Consulting LLP 商品コード 749561
出版日 ページ情報 英文 200 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.61円で換算しております。
Back to Top
生物製剤・バイオシミラーの世界市場の予測 Global Biologics and Biosimilars Market Size study, by Type(Antibody, Hormone, Growth Factors), by Applications (Tumor, Diabetes, Cardiovascular, Hemophilia, Other), by and Regional Forecasts 2018-2025
出版日: 2018年11月21日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界の生物製剤・バイオシミラー市場について調査分析し、市場力学、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 世界の生物製剤・バイオシミラー市場の定義と範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の生物製剤・バイオシミラー市場力学

  • 成長の見通し
  • 産業分析
  • アナリストの提言と結論

第5章 世界の生物製剤・バイオシミラー市場:種類別

  • 市場スナップショット
  • 市場実績:潜在的モデル
  • 二次セグメント分析
    • 抗体
    • ホルモン
    • 成長因子
    • その他

第6章 世界の生物製剤・バイオシミラー市場:適応別

  • 市場スナップショット
  • 市場実績:潜在的モデル
  • 二次セグメント分析
    • 腫瘍
    • 糖尿病
    • 心血管
    • 血友病
    • その他

第7章 世界の生物製剤・バイオシミラー市場:地域別分析

  • 市場スナップショット
  • 北米
  • 欧州
  • アジア
  • ラテンアメリカ
  • その他

第8章 競合インテリジェンス

  • 企業の市場シェア
  • 主な市場戦略
  • 企業プロファイル
    • Roche
    • Amgen
    • AbbVie
    • Sanofi-Aventis
    • Johnson & Johnson
    • Pfizer
    • Novo Nordisk
    • Eli Lily
    • Novartis
    • Merck
    • Biotech
    • Gelgen
    • Innovent
    • Ganlee
    • United Laboratories
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BIOLOGICS AND BIOSIMILARS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BIOLOGICS AND BIOSIMILARS MARKET
  • TABLE 3. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
  • TABLE 8. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
  • TABLE 9. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW BIOLOGICS AND BIOSIMILARS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, KEY TRENDS 2016
  • FIG 5. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA BIOLOGICS AND BIOSIMILARS MARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE BIOLOGICS AND BIOSIMILARS MARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC BIOLOGICS AND BIOSIMILARS MARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA BIOLOGICS AND BIOSIMILARS MARKET 2015 & 2025 (USD BILLON)
  • FIG 36. GLOBAL BIOLOGICS AND BIOSIMILARS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
目次

Global Biologics and Biosimilars Market to reach USD xxx billion by 2025.

Global Biologics and Biosimilars Market valued approximately USD xxx billion in 2017 is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2018-2025.

The Biologics and Biosimilars market is developing and expanding at a significant pace. The Biologics are mainly the medicines which are made from living cells through an highly complex manufacturing processes & must be administered and monitored under careful conditions. The Biologics are precisely utilized to prevent, diagnose, Treat and cure a variety of chronic and infectious diseases which mainly include Chronic Kidney Diseases, Cancer and autoimmune diseases. The biosimilar is exactly what its name implies that it is a biologic which is similar to another biologic drug which has been already approved by the Food & Drug Administration (FDA). In the present scenario, under United States Law, a biosimilar is specifically approved based on a showing that is highly similar to an already FDA approved biological product which is commonly known as reference product. It could not have an clinically meaningful differences in terms of safety & effectiveness from the reference product. The demand of Biologics and biosimilar is on the constant rise owing to the factors which includes rise in the prevalence of chronic and infectious diseases such as Cancer and Cardiovascular diseases, surge in the geriatric population, novel research & development advanced drugs along with escalating number of clinical trails on the globe. However, the manufacturing concerns or issues owing to complexity of drug molecules are hindering the growth of market. The surge in the research & development investments and activities considering the field of pharmaceuticals along with increase in the therapeutical applications are expected to offer new opportunities for the growth of biologics and biosimilars market on the global scenario.

The regional analysis of Global Biologics and Biosimilars Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 2018-2025.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Antibody
  • Hormone
  • Growth Factors
  • Other

By Applications:

  • Tumor
  • Diabetes
  • Cardiovascular
  • Haemophilia
  • Other

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2015, 2016

Base year - 2017

Forecast period - 2018 to 2025

The leading market players mainly include-

  • Roche
  • Amgen
  • AbbVie
  • Sanofi-Aventis
  • Johnson & Johnson
  • Pfizer
  • Novo Nordisk
  • Eli Lily
  • Novartis
  • Merck
  • Dong Bao
  • Ganlee
  • United Laboratories

Target Audience of the Global Biologics and Biosimilars Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Global Biologics and Biosimilars Market Definition and Scope

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Scope of The Study
  • 1.4. Years Considered for The Study
  • 1.5. Currency Conversion Rates
  • 1.6. Report Limitation

Chapter 2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Data Mining
    • 2.1.2. Analysis
    • 2.1.3. Market Estimation
    • 2.1.4. Validation
    • 2.1.5. Publishing
  • 2.2. Research Assumption

Chapter 3. Executive Summary

  • 3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
  • 3.2. Key Trends

Chapter 4. Global Biologics and Biosimilars Market Dynamics

  • 4.1. Growth Prospects
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Industry Analysis
    • 4.2.1. Porter's 5 Force Model
    • 4.2.2. PEST Analysis
    • 4.2.3. Value Chain Analysis
  • 4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Biologics and Biosimilars Market, By Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Global Biologics and Biosimilars Market, Sub Segment Analysis
    • 5.3.1. Antibody
      • 5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.2. Hormone
      • 5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.3. Growth Factors
      • 5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.3.4. Other
      • 5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Biologics and Biosimilars Market, By Applications

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Global Biologics and Biosimilars Market, Sub Segment Analysis
    • 6.3.1. Tumor
      • 6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.2. Diabetes
      • 6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.3. Cardiovascular
      • 6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.4. Hemophilia
      • 6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.3.5. Other
      • 6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Biologics and Biosimilars Market, by Regional Analysis

  • 7.1. Biologics and Biosimilars Market, Regional Market Snapshot (2015-2025)
  • 7.2. North America Biologics and Biosimilars Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.3. Europe Biologics and Biosimilars Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. France
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.4. Rest of Europe
      • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.4. Asia Biologics and Biosimilars Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.5. Latin America Biologics and Biosimilars Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Roche
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Amgen
    • 8.3.3. AbbVie
    • 8.3.4. Sanofi-Aventis
    • 8.3.5. Johnson & Johnson
    • 8.3.6. Pfizer
    • 8.3.7. Novo Nordisk
    • 8.3.8. Eli Lily
    • 8.3.9. Novartis
    • 8.3.10. Merck
    • 8.3.11. Biotech
    • 8.3.12. Gelgen
    • 8.3.13. Innovent
    • 8.3.14. Ganlee
    • 8.3.15. United Laboratories
Back to Top